In cancer, stem cells express Cx46 and form the functional channels required for tumorigenesis; blocking these channels results in decreased proliferation, self-renewal, and tumor formation [30,131], suggesting that targeting the low expression of Cxs channels and TNTs could be used to target GB and maybe other types of cancers. The gene discussed is GJA3; the disease is cancer.